A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2011
11/10/2011	WO2011051916A3 Stabilized protein formulations and use thereof
11/10/2011	WO2011037896A4 Polypeptide modification
11/10/2011	WO2011026898A3 Drug activation system
11/10/2011	WO2010119369A3 A medicinal cream made using silver sulphadiazine and chitosan and a process to make it
11/10/2011	WO2010109330A3 Cholesterol level lowering liposomes
11/10/2011	US20110275725 Glycerol ester active agent delivery systems and methods
11/10/2011	US20110275706 Pharmaceutical Compositions Containing Lipase Inhibitors
11/10/2011	US20110275704 Stable Formulations for Lyophilizing Therapeutic Particles
11/10/2011	US20110275700 Biodegradable polyketal polymers and methods for their formation and use
11/10/2011	US20110275599 Use of cold-stabilized methylated vegetable oils as an agricultural chemical coformulant
11/10/2011	US20110275590 Conjugates for cancer therapy and diagnosis
11/10/2011	US20110275567 Aqueous composition containing follicle-stimulating hormone
11/10/2011	US20110275565 Biocompatible polysaccharide-based hydrogels
11/10/2011	US20110274770 Antiseptic compositions and methods
11/10/2011	US20110274761 Polymer carrier
11/10/2011	US20110274760 Use of synthetic inorganic nanoparticles as carriers for ophthalmic and otic drugs
11/10/2011	US20110274731 Production Method Of Fine O/W Emulsion External Preparation
11/10/2011	US20110274712 Antigenic compositions
11/10/2011	US20110274676 Topical Use Of Probiotic Bacillus Spores To Prevent Or Control Microbial Infections
11/10/2011	US20110274630 Methods and compositions for extracting flavor and fragrance compounds and solubilizing essential oils
11/10/2011	US20110274620 Multifunctional degradable nanoparticles with control over size and functionalities
11/10/2011	CA2798923A1 Novel ophthalmic compositions
11/10/2011	CA2798145A1 Method and device for transdermal delivery of parathyroid hormone using a microprojection array
11/10/2011	CA2798139A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
11/10/2011	CA2798116A1 Topical pharmaceutical composition comprising heparin
11/10/2011	CA2795823A1 Methods of use of soluble cd24 for therapy of rheumatoid arthritis
11/10/2011	CA2794864A1 Compositions and methods useful for reducing the viscosity of protein-containing formulations
11/10/2011	CA2793571A1 Propynylaminoindan transdermal compositions
11/10/2011	CA2779798A1 Conjugation of staphylococcus aureus type 5 and type 8 capsular polysaccharides
11/10/2011	CA2776482A1 Compositions, gels and foams with rheology modulators and uses thereof
11/10/2011	CA2703532A1 Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
11/09/2011	EP2385080A1 Polypropylene resin pre-foamed particle and method for producing same, and polypropylene resin in-mold foaming molded article
11/09/2011	EP2385057A1 Peptide derivatives for biofunctionalization of silicon substrates and their applications
11/09/2011	EP2384767A1 Antibodies that bind OV064 and methods of use therefor
11/09/2011	EP2384744A1 Lipid-based dispersions useful for drug delivery
11/09/2011	EP2384742A1 Pharmaceutical excipient, method for its preparation and use thereof
11/09/2011	EP2384623A1 Powder composition for the prevention and treatment of animal hoof diseases
11/09/2011	EP2384188A1 Pharmaceutical microemulsion for preventing supramolecular aggregation of amphiphilic molecules
11/09/2011	EP1982721B1 Method of stabilizing s-adenosyl-l-methionine and stabilized composition
11/09/2011	EP1976531B1 Irradiated compositions and treatment of cancers with radiation in combination with taurolidine and/or taurultam
11/09/2011	EP1476182B1 Process for preparation of immunogenic formulations of variable peptidic epitopes
11/09/2011	EP1383516B1 Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
11/09/2011	EP1343508B1 Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
11/09/2011	EP1328624B1 B7-like molecules and uses thereof
11/09/2011	EP1284286B1 Alpha-isomaltosyltransferase, process for producing the same and use thereof
11/09/2011	EP1001815B1 Vectors derived from antibodies for transferring substances into cells
11/09/2011	CN1984675B Pharmaceutical compositions comprising botulinum neurotoxin, a non ionic surfactant, sodium chloride and sucrose
11/09/2011	CN1966547B Double-chain structured polyethylene glycol derivative preparation and its combination with pharmaceutical molecule
11/09/2011	CN1931232B Oil-in-water nanometer perilla seed oil emulsion oral liquid and its preparation process
11/09/2011	CN1913924B Solid sustained-releasing formulation comprising triptorelin acetate
11/09/2011	CN1899339B Medicinal composition for treating acute and chronic conjunctivitis for eye and its preparing method
11/09/2011	CN102238966A Transport-mediating colloidal pharmaceutical compounds
11/09/2011	CN102238965A Selective anticancer chimeric peptide
11/09/2011	CN102238964A Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
11/09/2011	CN102238958A Inhalant comprising modified superoxide dismutase
11/09/2011	CN102238946A Pharmaceutical composition for the controlled release of methylphenidate
11/09/2011	CN102238945A Pharmaceutical formulation 514
11/09/2011	CN102238940A Extrudate having spicular active substances
11/09/2011	CN102238939A Pharmaceutical aerosol composition
11/09/2011	CN102238938A Method of manufacturing solid microstructure and solid microstructure manufactured based on same
11/09/2011	CN102234658A Target quaternary ammonium salt cationic polymer lipid gene carrier, preparation method and application thereof
11/09/2011	CN102234334A Immunoglobulin chimeric monomer - dimer heterozygote
11/09/2011	CN102234331A Composition of Exendin-4 derivative and preparation method and application thereof
11/09/2011	CN102233135A Heightening substance coagulant
11/09/2011	CN102233130A Stable pharmaceutical preparation containing thymosin 1 derivatives
11/09/2011	CN102233129A Long-acting sustained release preparation for preventing or treating retinal damage, and preparation method thereof
11/09/2011	CN102232953A Medicinal composition containing Esopiclone and preparation method thereof
11/09/2011	CN102232951A Medicament for treating allergic conjunctivitis and preparation method thereof
11/09/2011	CN102232949A Drug dissolution increasing composition and preparation method thereof
11/09/2011	CN102232939A Novel mecobalamin sustained-release capsule and preparation method thereof
11/09/2011	CN102232937A Nanometer preparation and preparation method thereof
11/09/2011	CN102232935A Novel oral mecobalamin sustained-release tablets and preparation method thereof
11/09/2011	CN102232934A Pulsatile pellet, pulsatile orally disintegrating tablet containing same, and preparation methods and applications thereof
11/09/2011	CN102232933A Tumor-targeting albumin nano-lyophilized powder injection preparation and preparation method thereof
11/09/2011	CN102232932A Pectin-adriamycin coniuncate lyophilized preparation, and preparation method thereof
11/09/2011	CN102232931A Formula of asarone for injection and preparation method thereof
11/09/2011	CN102232930A Landiolol hydrochloride pharmaceutical compositions and preparation methods thereof
11/09/2011	CN102232928A Nimesulide sustained-release suspension and preparation method thereof
11/09/2011	CN102232927A Vincristine-PEG-PLGA segmented copolymer nanoparticle, its preparation method and use
11/09/2011	CN102232926A Oral taxol nanoparticles and preparation method thereof
11/09/2011	CN102232921A Technique for preparing rod-like sustained-release preparation by using blending-modified corn zein as skeleton material and preparation prepared by technique
11/09/2011	CN101966151B Trimipramine maleate liposome solid preparation
11/09/2011	CN101961306B Preparation method of low melting point drug solid dispersion
11/09/2011	CN101904822B Faropenem sodium freeze-drying powder and preparation method thereof
11/09/2011	CN101856323B Beta-CD inclusion suppository containing rana chensinensis antibacterial peptide and preparation method thereof
11/09/2011	CN101829046B Amphipathilic block polymer micelle nano medicament carrying system and preparation method
11/09/2011	CN101766577B Solid preparation of clopidogrel free alkali and preparation process thereof
11/09/2011	CN101708156B Camptothecin medicament injection solution and injection and preparation method thereof
11/09/2011	CN101703486B Novel flutamide tablets and method for preparing same
11/09/2011	CN101696278B Preparation method of Trolox- chitosan self-assembly nano-particles
11/09/2011	CN101658485B Nanometer hybridized hydrogel with durable broad spectrum antibacterial performance and preparation method thereof
11/09/2011	CN101637450B Levocarnitine liposomes injection and its preparation method
11/09/2011	CN101623256B Ivermectin nanoemulsion drug combination and preparation method thereof
11/09/2011	CN101579329B Bevantolol hydrochloride sustained release preparation
11/09/2011	CN101536982B Trastuzumab-modified toxin protein-coated PEG immune liposome and preparation and application thereof
11/09/2011	CN101507710B Safe selenium-complement sustained-release microspheres and preparation method thereof
11/09/2011	CN101455645B Preparation method of medicine microspheres using plant soy protein as carrier
11/09/2011	CN101420982B Dry direct compression fast disintegrating tablet
11/09/2011	CN101371842B Lornoxicam microsphere and preparation method thereof
11/09/2011	CN101278932B Sustained release medicinal compositions containing Zaltoprofen, preparation method and application thereof

1 ... 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 ... 1712